PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression
<h4>Background</h4> Protection of islets without systemic immunosuppression has been a long-sought goal in the islet transplant field. We conducted a pilot biocompatibility/safety study in healthy dogs followed by a dose-finding efficacy study in diabetic dogs using polyethylene glycol diacrylate (P...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Public Library of Science (PLoS)
2022-01-01
|
| Ráidu: | PLoS ONE |
| Liŋkkat: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132281/?tool=EBI |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|